Stay informed with the latest updates for the inheritable blood disorders community. IndustryFDA Accepts Biogen's Application for Longer-Lasting FVIII ProductApr 1, 2013 IndustryPfizer Halts Development of HCV DrugApr 1, 2013 Advocacy & LegislativeWashington Days Breaks Attendance RecordApr 1, 2013 Advocacy & LegislativeNHF Comments on Letter Regarding ExchangesApr 1, 2013 IndustryCSL's FXIII Product Approved for Expanded UseApr 1, 2013 IndustryCangene to Acquire IB1001 from InspirationMar 1, 2013 Advocacy & LegislativeNHF Comments on Medicaid, Marketplaces RuleMar 1, 2013 NBDF & CommunityWeb Videos Combine Humor and EducationMar 1, 2013 IndustryIdenix Ceases Development of Two HCV DrugsMar 1, 2013 IndustryGilead's HCV Therapy Trials On TrackMar 1, 2013 IndustryBiogen Reports A-LONG and B-LONG Studies ProgressMar 1, 2013 Advocacy & LegislativeWashington Days Focus: Hemophilia Program Funding and Specialty Tiers Bill…Feb 1, 2013 Advocacy & LegislativeBackground Information on Washington Budget PolicyFeb 1, 2013 IndustryCSL Behring Enrolls Pediatric Patient in Hemophilia B StudyFeb 1, 2013 IndustryGreen Cross Initiates Phase III Trial of rFVIII ProductFeb 1, 2013 Pagination First page Previous page … Page 81 Page 82 Page 83 Page 84 Current page 85 Page 86 Page 87 Page 88 Page 89 … Next page Last page
